Leading Australian scientist at forefront of genetic breast cancer research wins major industry award

GSK Australia
  • Professor Georgia Chenevix-Trench becomes the 42nd winner of the GSK Award for Research Excellence 2022.
  • This year, Professor Chenevix-Trench was also named one of the most influential health figures in Queensland.
  • With over thirty years of experience in cancer genetics, Professor Chenevix-Trench is a world-renowned scientist who is at the forefront of cancer research in Australia.
  • With her collaborators, Professor Chenevix-Trench discovered over 240 regions of a genome that are likely to affect a person’s risk of developing breast cancer.
/Public Release.